95 related articles for article (PubMed ID: 21535412)
41. Loading of Argonaute Protein with Small Duplex RNA in Cellular Extracts.
Gagnon KT
Methods Mol Biol; 2016; 1421():53-67. PubMed ID: 26965257
[TBL] [Abstract][Full Text] [Related]
42. Terminal Duplex Stability and Nucleotide Identity Differentially Control siRNA Loading and Activity in RNA Interference.
Angart PA; Carlson RJ; Adu-Berchie K; Walton SP
Nucleic Acid Ther; 2016 Oct; 26(5):309-317. PubMed ID: 27399870
[TBL] [Abstract][Full Text] [Related]
43. NUDT21 regulates 3'-UTR length and microRNA-mediated gene silencing in hepatocellular carcinoma.
Sun M; Ding J; Li D; Yang G; Cheng Z; Zhu Q
Cancer Lett; 2017 Dec; 410():158-168. PubMed ID: 28964783
[TBL] [Abstract][Full Text] [Related]
44. Terminus-free siRNA prepared by photo-crosslinking activated via slicing by Ago2.
Kamiya Y; Iishiba K; Doi T; Tsuda K; Kashida H; Asanuma H
Biomater Sci; 2015 Dec; 3(12):1534-8. PubMed ID: 26526389
[TBL] [Abstract][Full Text] [Related]
45. Argonaute-2 enhances suppression of human cytomegalovirus replication by polycistronic short hairpin RNAs targeting UL46, UL70 and UL122.
Shao PL; Lu MY; Liau YJ; Chao MF; Chang LY; Lu CY; Kao CL; Chang SY; Chi YH; Huang LM
Antivir Ther; 2011; 16(5):741-9. PubMed ID: 21817196
[TBL] [Abstract][Full Text] [Related]
46. [Vascular endothelial growth factor antisense oligodeoxynucleotide enhance drug-sensitivity of myeloid leukemia cells to homoharringtonine].
Fei J; Zhang H
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):27-30. PubMed ID: 15946505
[TBL] [Abstract][Full Text] [Related]
47. Argonaute2 is a potential target for siRNA-based cancer therapy for HT1080 human fibrosarcoma.
Tagami T; Suzuki T; Hirose K; Barichello JM; Yamazaki N; Asai T; Oku N; Ishida T; Kiwada H
Drug Deliv Transl Res; 2011 Aug; 1(4):277-88. PubMed ID: 25788362
[TBL] [Abstract][Full Text] [Related]
48. Cellular Approaches in Investigating Argonaute2-Dependent RNA Silencing.
Zhang C; Seo J; Nakamura T
Methods Mol Biol; 2018; 1680():205-215. PubMed ID: 29030851
[TBL] [Abstract][Full Text] [Related]
49. Differences in silencing of mismatched targets by sliced versus diced siRNAs.
Sun G; Wang J; Huang Y; Yuan CW; Zhang K; Hu S; Chen L; Lin RJ; Yen Y; Riggs AD
Nucleic Acids Res; 2018 Jul; 46(13):6806-6822. PubMed ID: 29718312
[TBL] [Abstract][Full Text] [Related]
50. Argonaute 2 Binds Directly to tRNA Genes and Promotes Gene Repression in cis.
Woolnough JL; Atwood BL; Giles KE
Mol Cell Biol; 2015 Jul; 35(13):2278-94. PubMed ID: 25918241
[TBL] [Abstract][Full Text] [Related]
51. Strong reduction of AGO2 expression in melanoma and cellular consequences.
Völler D; Reinders J; Meister G; Bosserhoff AK
Br J Cancer; 2013 Dec; 109(12):3116-24. PubMed ID: 24169347
[TBL] [Abstract][Full Text] [Related]
52. AGO2 and its partners: a silencing complex, a chromatin modulator, and new features.
Li X; Wang X; Cheng Z; Zhu Q
Crit Rev Biochem Mol Biol; 2020 Feb; 55(1):33-53. PubMed ID: 32164444
[TBL] [Abstract][Full Text] [Related]
53. Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation.
Yi S; Wen L; He J; Wang Y; Zhao F; Zhao J; Zhao Z; Cui G; Chen Y
Ann Hematol; 2015 Feb; 94(2):201-10. PubMed ID: 25242579
[TBL] [Abstract][Full Text] [Related]
54. Argonaute 2-dependent Regulation of Gene Expression by Single-stranded miRNA Mimics.
Matsui M; Prakash TP; Corey DR
Mol Ther; 2016 May; 24(5):946-55. PubMed ID: 26903376
[TBL] [Abstract][Full Text] [Related]
55. Anti-Leukemic Activity of Shikonin: Role of ERP57 in Shikonin Induced Apoptosis in Acute Myeloid Leukemia.
Trivedi R; Müller GA; Rathore MS; Mishra DP; Dihazi H
Cell Physiol Biochem; 2016; 39(2):604-16. PubMed ID: 27415599
[TBL] [Abstract][Full Text] [Related]
56. The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells.
Ge YL; Zhang X; Zhang JY; Hou L; Tian RH
Int Immunopharmacol; 2009 Apr; 9(4):389-95. PubMed ID: 19162240
[TBL] [Abstract][Full Text] [Related]
57. Argonaute 2 sustains the gene expression program driving human monocytic differentiation of acute myeloid leukemia cells.
Iosue I; Quaranta R; Masciarelli S; Fontemaggi G; Batassa EM; Bertolami C; Ottone T; Divona M; Salvatori B; Padula F; Fatica A; Lo-Coco F; Nervi C; Fazi F
Cell Death Dis; 2013 Nov; 4(11):e926. PubMed ID: 24263100
[TBL] [Abstract][Full Text] [Related]
58. Transfection of siRNAs can alter miRNA levels and trigger non-specific protein degradation in mammalian cells.
Liang XH; Hart CE; Crooke ST
Biochim Biophys Acta; 2013 May; 1829(5):455-68. PubMed ID: 23403288
[TBL] [Abstract][Full Text] [Related]
59. Hypoxia regulates overall mRNA homeostasis by inducing Met
Zhang H; Zhao X; Guo Y; Chen R; He J; Li L; Qiang Z; Yang Q; Liu X; Huang C; Lu R; Fang J; Cao Y; Huang J; Wang Y; Huang J; Chen GQ; Cheng J; Yu J
Nat Commun; 2021 Sep; 12(1):5416. PubMed ID: 34518544
[TBL] [Abstract][Full Text] [Related]
60. miR-15b-AGO2 play a critical role in HTR8/SVneo invasion and in a model of angiogenesis defects related to inflammation.
Yang M; Chen Y; Chen L; Wang K; Pan T; Liu X; Xu W
Placenta; 2016 May; 41():62-73. PubMed ID: 27208409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
